Compare DTIL & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DTIL | SNFCA |
|---|---|---|
| Founded | 2006 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.7M | 248.9M |
| IPO Year | 2019 | 1995 |
| Metric | DTIL | SNFCA |
|---|---|---|
| Price | $7.50 | $9.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $45.00 | N/A |
| AVG Volume (30 Days) | ★ 299.3K | 24.5K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 13.51 |
| EPS | N/A | ★ 0.60 |
| Revenue | ★ $1,070,000,000.00 | $344,587,538.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $34.48 |
| Revenue Growth | N/A | ★ 3.01 |
| 52 Week Low | $3.53 | $7.70 |
| 52 Week High | $9.62 | $10.23 |
| Indicator | DTIL | SNFCA |
|---|---|---|
| Relative Strength Index (RSI) | 49.97 | 42.61 |
| Support Level | $6.62 | $9.14 |
| Resistance Level | $7.96 | $9.40 |
| Average True Range (ATR) | 0.41 | 0.28 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 72.64 | 28.16 |
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
Security National Financial Corp is a holding company providing insurance services. The company operates in three reportable business segments: Life insurance, Cemetery and Mortuary, and Mortgages. The life insurance segment sells and services selected lines of life insurance, annuity products, and accident and health insurance. The cemetery and mortuary segment engages in pre-need selling of funeral, cemetery, mortuary, and cremation services through its cemetery and mortuary locations. The mortgage segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and other real estate projects. It derives the majority of revenue from Life Insurance segment.